Picture of Acceler8 Ventures logo

AC8 Acceler8 Ventures News Story

0.000.00%
gb flag iconLast trade - 00:00
FinancialsHighly SpeculativeMicro CapSucker Stock

REG - Acceler8 Ventures - Full Year Results for the period ended 31 Dec 2022

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230427:nRSa6809Xa&default-theme=true

RNS Number : 6809X  Acceler8 Ventures PLC  27 April 2023

27 April 2023

ACCELER8 VENTURES PLC

 ("AC8" or the "Company")

Full Year Results for the period ended 31 December 2022

Acceler8 Ventures Plc (LSE: AC8) has today published its Annual Report and
Financial Statements for the period ended 31 December 2022 (the "Annual
Report").

In accordance with Listing Rule 9.6.1 copies of the Annual Report have been
submitted to the UK Listing Authority and will shortly be available to view
on the Company's website at https://acceler8.ventures
(https://acceler8.ventures) and will be shortly available for inspection from
the National Storage Mechanism
at: https://data.fca.org.uk/#/nsm/nationalstoragemechanis
(https://data.fca.org.uk/#/nsm/nationalstoragemechanism) m
(https://data.fca.org.uk/#/nsm/nationalstoragemechanism)

LEI: 2138004B1HKZP1OR2C72

 

Enquiries

 Tessera Investment Management Limited

 Tony Morris                              +44 (0) 7742 189145

 

Chairman's Statement

I am pleased to present the financial results for Acceler8 Ventures Plc
("AC8", the "Company") and its subsidiary (together the "Group") for the year
ended 31 December 2022.

During the year and post year end we have remained focused on executing our
buy and build strategy and continue to assess investment and acquisition
opportunities where we believe there to be sustainable growth potential both
organically, and through acquisition. These will typically be fundamentally
sound assets located in the UK or internationally, including Europe and the
Asia Pacific region, where tangible opportunities exist to drive strategic,
operational and performance improvements.

Continuing general political and macroeconomic uncertainty, which we face both
within the UK and internationally has undoubtedly caused some hesitancy in
corporate decision making, however with it, also brings opportunity and as
such, we remain positive around our chosen areas of focus and look forward to
updating shareholders in due course as our investment and acquisition plans
develop during the new financial year.

Finally, I would like to take this opportunity to thank our loyal shareholders
for their continued support and patience while we diligently source and
evaluate a number of exciting propositions that, if secured, we believe have
the potential to deliver value.

David Williams

Chairman

26 April 2023

 

Report of the Directors

The Directors of the Company present their report for the year ended 31
December 2022.

PRINCIPAL ACTIVITY AND BUSINESS REVIEW

For the financial year ended 31 December 2022, the Group and Company's
principal activities were that of a holding group and company respectively.
The Group and Company have actively pursued their strategy through the
sourcing and assessment of acquisition and investment opportunities across
gaming, media and entertainment, software and technology, industrials and
business services sectors.

RESULTS

During the year, AC8 recorded a loss of £185,117 (2021: loss of £383,784)
and the loss per share was £0.25 (2021: loss per share of £0.72), reflecting
moderate monthly operating expenses of the Group. The Group and Company had
cash reserves at the end of the year of £244,948 (2021: £432,440).

DIVIDENDS

At this point in the Company's development, it does not anticipate declaring
any dividends in the foreseeable future. As such, the Directors do not
recommend the payment of a dividend for the year.

FUTURE DEVELOPMENTS

The Directors expect to continue to execute the Group's strategy in sourcing
and assessing acquisition and investment opportunities across its stated
sectors of focus.

KEY PERFORMANCE INDICATORS

The Board continues to focus on maximising shareholder value through pursuing
its acquisition strategy.

As such, the Board will identify and develop appropriate key performance
indicators after an acquisition has been completed.

GOING CONCERN

The Directors, having made due and careful enquiry, are of the opinion that
the Group and Company have adequate working capital to execute their
operations over the next 12 months. The Group and Company's unaudited cash
balance as at 21 April 2023 was £162,521, and excluding the consummation of
any investment or acquisition which will likely require specific funding, has
adequate resources available to fund the on-going forecast operating expenses
for at least twelve months following approval of the financial statements.
Having also performed additional stress testing on the forecasts, the
Directors are comfortable there are sufficient mitigating actions on the
incurring of expenditure within the business that could be taken, to ensure
the business can meet its ongoing liabilities as they fall due. The Directors,
therefore, have made an informed judgement at the time of approving the
financial statements, that there is a reasonable expectation that the Group
and Company have adequate resources to continue in operational existence for
the foreseeable future. As a result, the Directors have adopted the going
concern basis of accounting in preparing the annual financial statements (see
Note 2).

RISK MANAGEMENT

In order to execute the Group's strategy, the Company and its subsidiaries
will be exposed to both financial and non-financial risks. The Board has
overall responsibility for the Group's risk management and it is the Board's
role to consider whether those risks identified by management are acceptable
within the Group's strategy and risk appetite. The Board therefore
periodically reviews the principal risks and considers how effective and
appropriate the controls that management has in place to mitigate the risk
exposure are and will make recommendations to management accordingly.

As the Company had not completed an investment or acquisition in the period,
it has limited financial statements and/or historical financial data, and
limited trading history. As such, the Company during the period was subject to
the risks and uncertainties associated with an early-stage acquisition
company, including the risk that the Company will not achieve its investment
objectives and that the value of any investment or acquisition could decline
and may result in the partial or complete loss of capital invested. The past
performance of investee companies or assets managed by the Directors will not
necessarily be a guide to future business, results of operations, financial
condition or prospects of the Company.

In order to mitigate against these risks, the Directors continue to undertake
thorough due diligence on investment opportunities and acquisition targets, to
a level considered reasonable and appropriate by the Company on a case-by-case
basis, including the potential commissioning of third-party specialist reports
as appropriate. Following completion of any investment or acquisition, it is
intended that any investments or assets will be overseen by the Directors and
assisted by the Company's professional advisers.

Financial Risk Management

The Directors consider the Group to be exposed to the following financial
risks:

a.      Price risk: the price paid for securities is subject to market
movement that may have an impact on the operations of the Group when raising
finance;

b.      Cash flow interest rate risk: the Group has cash balances which
exposed it to movement in the market interest rates; and

c.      Liquidity risk: the Group manages its cash requirements through
detailed forecasting and planning for amount and timing of payments and
receipts of interest income, to ensure cash resources are available when
required.

Given the relatively small size and operation of the Group in the year, the
Directors have not delegated the responsibility of risk monitoring to a
sub-committee of the Board, but closely monitor the risks on a periodic basis.
The Directors consider their exposure in the financial year to have been low.
Refer to Note 14 for assessment of the risks arising from financial
instruments.

Non-financial Risk Management

The non-financial risk factors for the year ended 31 December 2022 did not
materially change from those set out in AC8's Prospectus dated 14 July 2021.

GREENHOUSE GAS EMISSIONS, ENERGY CONSUMPTION AND ENERGY EFFICIENCY

As the Company has not completed its first acquisition and has only two
Directors, limited travel and no premises, the Directors do not consider any
disclosure under the Task Force on Climate-related Financial Disclosures is
required at this juncture, however the Company will continue to review this
position as it executes its investment and acquisition strategy.

POLITICAL CONTRIBUTIONS

The Company has made no political contributions during the year.

CHARITABLE DONATIONS

The Company has made no charitable donations during the year.

POST BALANCE SHEET EVENTS

There have been no significant post balance sheet events. See Note 20.

SHARE CAPITAL

Details of the Company's share capital is set out in Note 15. The Company's
share capital consists of one class of ordinary share, which does not carry
rights to fixed income. As at 31 December 2022, there were 750,000 ordinary
shares of 1p par value each in issue.

SIGNIFICANT SHAREHOLDERS

As at 21 April 2023, the Company had been advised of the following notifiable
interests (whether directly or indirectly held) in voting rights.

 Name                                    Shareholding  Percentage
 David Williams                          275,000       36.7%
 Giles Willits                           100,000       13.3%
 Bank of New York Nominees Limited       78,000        10.4%
 Hargreaves Lansdown (Nominees) Limited  51,778        6.9%
 Helen Johnson                           37,500        5.0%
 Transact Nominees Limited               33,333        4.4%
 Vidacos Nominees Limited                27,110        3.6%
 Cenkos Nominee Limited                  25,258        3.4%
 David Morris                            25,000        3.3%
 Tessera Investment Management Limited   25,000        3.3%

As at 21 April 2023, the Directors in aggregate held 375,000 ordinary shares,
which represents 50 per cent. of the Company's issued share capital.

COMPANY DIRECTORS

The Directors during the year and summaries of their experience are set out
below.

David Williams Non-Executive Chairman

David has significant experience in investment markets, serving as Chairman in
executive and non-executive capacities for a number of public and private
companies. He has overseen the development of these companies, raising in
excess of £1 billion of capital to support both organic and acquisitive
growth initiatives.

David was the original founder of Marwyn Capital LLP, the award-winning
investment management company. David was also formerly Chairman of
Entertainment One Ltd. (LSE: ETO), Zetar plc, and Waste Recycling Group Plc,
and Non-Executive director of Breedon Group plc (AIM: BREE). He currently
serves as Non-Executive Chairman of the AIM-quoted cyber security business,
Shearwater Group plc (AIM: SWG) and Main Market listed Red Capital Plc (LSE:
REDC) and is a Non-Executive director of Bay Capital Plc (LSE: BAY).

Giles Willits Non-Executive Director

Giles has more than 20 years' experience in senior leadership and financial
roles in multiple household name businesses, and was most recently, Chief
Financial Officer and board director of IG Design Group plc (AIM: IGR), the
world's largest consumer gift packaging organisation.

Prior to his role at IG Design Group, Giles was Chief Financial Officer of
Entertainment One Ltd. (LSE: ETO), having joined prior to its admission to
trading on AIM in 2007, during which time the business grew organically and
through acquisitions to a market capitalisation of over £1 billion, becoming
a FTSE250 premium listed organisation. He was also formerly Director of Group
Finance at J Sainsbury plc and qualified as a chartered accountant at
PricewaterhouseCoopers.

During his extensive career, Giles has completed numerous corporate
acquisitions as part of buy-and-build strategies, acquiring private and
publicly listed companies, stepping companies up from AIM to the Main Market,
as well as leading on equity and debt financings in support of organic growth
and acquisition activity.

The Directors who held office during the year and their beneficial interest in
the share capital of the Company at 31 December 2022 were as follows:

                 31 December 2022
 David Williams  275,000
 Giles Willits   100,000
                 375,000

DIRECTORS' REMUNERATION

The Chairman and Non-Executive Director are entitled to fees of £20,000 each
per annum for their respective roles within the Company, as per their service
agreements entered into on 13 July 2021. There are no other benefits paid to
Directors outside of their service fees, save for ordinary course reimbursable
expenses properly incurred in the performing of their duties as Directors. The
Company does not operate a pension scheme.

                         Benefits  31 December 2022
                 Salary  in kind   Total
 Director        £       £         £
 David Williams  20,000  -         20,000
 Giles Willits   20,000  -         20,000
                 40,000  -         40,000

In addition to the Directors' fee entitlements outlined above, the Directors
are also participants in the Subco Incentive Scheme as detailed below.

SUBCO INCENTIVE SCHEME

The Directors believe that the success of the Company will depend to a high
degree on the future performance of key employees and advisers in executing
and supporting the Company's growth strategy. The Company has therefore
established equity-based incentive arrangements which are, and will continue
to be, an important means of retaining, attracting and motivating key
employees, consultants and advisers, and also for aligning the interests of
the Directors with those of shareholders.

On 27 May 2021, the Group created a new Subco Incentive Scheme within its
wholly owned subsidiary Acceler8 Ventures Subco Limited. Under the terms of
the Subco Incentive Scheme, scheme participants are only rewarded if a
predetermined level of shareholder value is created over a three to five year
period or upon a change of control of the Company or Subco (whichever occurs
first), calculated on a formula basis by reference to the growth in market
capitalisation of the Company, following adjustments for the issue of any new
ordinary shares and taking into account dividends and capital returns
("Shareholder Value"), realised by the exercise by the beneficiaries of a put
option in respect of their shares in Subco and satisfied either in cash or by
the issue of new ordinary shares at the election of the Company.

Under these arrangements in place, participants are entitled up to 15 per
cent. of the Shareholder Value created, subject to such Shareholder Value
having increased by at least 12.5 per cent. per annum compounded over a period
of between three and five years from Admission, or following a change of
control of the Company or Subco.

In order to implement the Subco Incentive Scheme, the Company as sole
shareholder of Subco, approved the creation of a new share class in Subco (the
"B Shares"). At the same time the Subco's existing ordinary shares were
redesignated A Shares. The B Shares do not have voting or dividend rights.

On 27 May 2021, David Williams, Chairman of the Company, Giles Willits, a
Non-Executive Director of the Company, and Kathleen Long and Anthony Morris,
Directors of Tessera Investment Management Limited, became the first
participants in the Subco Incentive Scheme ("Founder Participants"), and as
such, the proportion of Shareholder Value attaching to the Subco Incentive
Scheme is 2.9 per cent. of a total cap of 15 per cent.

The Founder Participants and their respective holdings are outlined below.

                 Subco
 Participant     B shares held
 David Williams  1,667
 Giles Willits   24,000
 Kathleen Long   1,667
 Anthony Morris  1,666
                 29,000

CORPORATE GOVERNANCE

As a Jersey company and a company with a Standard Listing, the Company is not
required to comply with the provisions of the UK Corporate Governance Code
2018. Furthermore, there is no applicable regime of corporate governance to
which the directors of a Jersey company must adhere over and above the general
fiduciary duties and duties of care, skill and diligence imposed on such
directors under Jersey law. Notwithstanding this, the Directors are committed
to maintaining high standards of corporate governance and will be responsible
for carrying out the Company's objectives and implementing its business
strategy.

All investment, acquisition, divestment and other strategic decisions are
considered and determined by the Board. At present, the Board reviews
investment and acquisition opportunities on an as required basis, and meets
regularly with its Strategic Advisor to discuss possible inorganic growth
opportunities, as well as monitor deal flow and investment and acquisitions in
progress, and review the Company's strategy to ensure that it remains aligned
to the delivery of shareholder value. Those investment and acquisition
opportunities that are assessed by the Board (with support from its Strategic
Advisor) are considered in light of the investment and acquisition criteria as
detailed in the Company's Prospectus. In addition, as part of the investment
and acquisition screening process, the Company will augment Board and
Strategic Advisor capability on a case by case basis as required with industry
and operating partner input, where deep domain expertise can be accessed. The
Board provides leadership within a framework of prudent and effective
controls. The Board has established the corporate governance values of the
Company and has overall responsibility for setting the Company's strategic
aims, defining the business plan and strategy and managing the financial and
operational resources of the Company.

In this regard, the Board, so far as is practicable given the Company's size
and stage of its development, has voluntarily adopted the QCA Code as its
chosen corporate governance framework. There are certain provisions of the QCA
Code which the Company will not adhere to currently, and their adoption will
be delayed until such time as the Directors believe it is appropriate to do
so. It is anticipated that this will occur concurrently with the Company's
first material investment or acquisition.

Following such an acquisition, the Company will seek to develop its corporate
governance position, and will address key differences to the QCA Code.
Specifically, it is anticipated this will include:

i.       the augmentation of the Board with suitably qualified
additional executive and non-executive directors including independents;

ii       the implementation of audit, remuneration and nomination
committees with appropriate terms of reference;

iii.      a formalised annual evaluation and review process covering the
Board and Committees, including succession planning;

iv.     the publication of KPIs;

v.      the development of a corporate and social responsibility policy;
and

vi.     an enhanced risk management and governance framework tailored to
the operating assets and strategic direction of the enlarged entity.

ROLE OF THE BOARD

The Board is responsible for the management of the business of the Group,
setting the strategic direction of the Group and establishing the policies of
the Group. It is the Directors' responsibility to oversee the financial
position of the Group and monitor the business and affairs of the Group, on
behalf of the shareholders, to whom they are accountable. The primary duty of
the Directors is to act in the best interests of the Group and Company at all
times. The Board also addresses issues relating to internal control and the
Group's approach to risk management and has formally adopted an
anti-corruption and bribery policy.

The Group does not have a separate investing committee and therefore the Board
as a whole will be responsible for sourcing acquisitions and ensuring that
opportunities are in conformity with the Group's strategy.

The Group holds four formal Board meetings a year, with unscheduled meetings
as matters arise which require the attention of the Board. Formal Board
meetings are timed to link to key events in the Group's corporate calendar.
Outside the scheduled and unscheduled meetings of the Board, the Directors
maintain frequent contact with each other to keep them fully briefed on the
Group's operations.

INTERNAL CONTROLS

The Board acknowledges its responsibility for establishing and monitoring the
Group's systems of internal control. Although no system of internal control
can provide absolute assurance against material misstatement or loss, the
Group's systems are designed to provide the Directors with reasonable
assurance that problems can be identified on a timely basis and dealt with
appropriately.

The Group maintains an appropriate process for financial reporting. The annual
budget is reviewed and approved by the Board before being formally adopted.

Other key procedures that have been established and which are designed to
provide effective control are as follows:

Management structure - The Board meets regularly on a formal and informal
basis to discuss all issues affecting the Group.

Investment appraisal - The Group has a robust framework for investment
appraisal and approval is required by the Board, where appropriate.

Share dealing and inside information - the Company has adopted a share dealing
code regulating trading and confidentiality of inside information for the
Directors and other persons discharging managerial responsibilities (and their
persons closely associated) which contains provisions appropriate for a
company whose shares are admitted to trading on the Official List
(particularly relating to dealing during closed periods which will be in line
with the Market Abuse Regulation). The Company takes all reasonable steps to
ensure compliance by the Directors and any relevant employees with the terms
of that share dealing code.

The Board reviews the effectiveness of the systems of internal control and
considers the major business risks and the control environment. No significant
deficiencies have come to light during the year and no weaknesses in internal
financial control have resulted in any material losses, or contingencies which
would require disclosure, as recommended by the guidance for Directors on
reporting on internal financial control.

The Directors are focused on careful management of the Group's cash and
financial resources through Board level approvals. At such time that the Group
completes an acquisition, the Directors anticipate that the Group's financial
position and prospects procedures regime will be updated and expanded as
necessary to cater for the nature of the Group's business following completion
of its inaugural investment or acquisition.

BOARD EVALUATION

In the year, the Board evaluation process was limited to an ongoing informal
evaluation of the performance of the Board by each Director. This will be
replaced by a formal, annual evaluation process once the Group has completed
its first acquisition.

EXTERNAL ADVISERS

The Board accessed the following external advisers during the year and post
the year end:

Mayer Brown International LLP and Ogier (Jersey) LLP - legal

Tessera Investment Management Limited - capital markets and M&A

JTC Plc - company secretarial, governance and regulatory filings

CONFLICTS OF INTEREST

A Director has a duty to avoid a situation in which he or she has, or can
have, a direct or indirect interest that conflicts, or possibly may conflict,
with the interests of the Company. The Board has satisfied itself that there
are no conflicts of interest where the Directors have appointments on the
Boards of, or relationships with, companies outside the Company. Furthermore,
the Board requires Directors to declare all appointments and other situations
which could result in a possible conflict of interest, and therefore believes
it has a robust framework to deal with any conflict of interest should it
arise.

RELATIONS WITH SHAREHOLDERS

The Chairman is the Group's principal spokesperson with investors, fund
managers, the press and other interested parties. As well as the Annual
General Meeting with shareholders, the other Directors may give formal
presentations at investor road shows following the announcement of interim and
full year results.

Notice of this year's Annual General Meeting will shortly be sent to
shareholders.

DISCLOSURE OF INFORMATION TO THE INDEPENDENT AUDITOR

So far as the Directors are aware, there is no relevant audit information of
which the Group and Company's independent auditor is unaware, and each
Director has taken all the steps that he ought to have taken as a Director in
order to make himself aware of any relevant audit information and to establish
that the Group and Company's independent auditor is aware of that information.

The Directors confirm to the best of their knowledge that:

·         the financial statements, prepared in accordance with the
relevant financial reporting framework, give a true and fair view of the
assets, liabilities, financial position and profit or loss of the Group and
Company and the undertakings included in the consolidation taken as whole;

·         the Chairman's Statement and Report of the Directors
includes a fair review of the development and performance of the business and
the position of the Group and Company and the undertakings included in the
consolidation taken as a whole, together with a description of the principal
risks and uncertainties that they face; and

·         the annual report and accounts, taken as a whole, are fair,
balanced and understandable and provide the information necessary for
shareholders to assess the Group and Company's position and performance,
business model and strategy.

INDEPENDENT AUDITOR

The independent auditor, MHA MacIntyre Hudson, will be proposed for
re-appointment at the forthcoming Annual General Meeting.

ON BEHALF OF THE BOARD

David Williams

Chairman

26 April 2023

 

Statement of Directors' Responsibilities

The Directors are responsible for preparing the Directors' report and the
financial statements in accordance with applicable law and regulations.

Jersey Company law requires the directors to prepare financial statements for
each financial year. Under that law the directors have elected to prepare the
financial statements in accordance with International Financial Reporting
Standards as adopted by the United Kingdom ("IFRS"). Under company law the
Directors must not approve the financial statements unless they are satisfied
that they give a true and fair view of the state of affairs of the Group and
Company and of the profit or loss of the Group for that year.

In preparing these financial statements, the Directors are required to:

·         select suitable accounting policies and then apply them
consistently;

·         make judgements and estimates that are reasonable and
prudent;

·         state whether the Group financial statements have been
prepared in accordance with IFRS as adopted by the United Kingdom;

·         state whether the Company financial statements have been
prepared in accordance with FRS 101 "Reduced disclosure framework"; and

·         prepare the financial statements on the going concern basis
unless it is inappropriate to presume that the Company will continue in
business.

The Directors are responsible for keeping proper accounting records that are
sufficient to show and explain the Group and Company's transactions and
disclose with reasonable accuracy at any time the financial position of the
Group and Company and enable them to ensure that the financial statements
comply with the Companies (Jersey) Law 1991. They are also responsible for
safeguarding the assets of the Group and Company and hence for taking
reasonable steps for the prevention and detection of fraud and other
irregularities.

The maintenance and integrity of the Group's website is the responsibility of
the Directors. The work carried out by the independent auditors does not
involve the consideration of these matters and, accordingly, the independent
auditors accept no responsibility for any changes that may have occurred in
the accounts since they were initially presented on the website. Legislation
in Jersey governing the preparation and dissemination of the accounts and the
other information included in annual reports may differ from legislation in
other jurisdictions.

 

Consolidated Statement of Comprehensive Income

For the year ended 31 December 2022

                                                                           9 month
                                                              Year ended   period ended
                                                              31 December  31 December
                                                              2022         2021
                                                        Note  £            £
 Administrative expenses                                      (185,232)    (383,784)
 Operating loss                                         6     (185,232)    (383,784)
 Interest receivable                                          115          -
 Loss on ordinary activities before taxation                  (185,117)    (383,784)
 Taxation charge                                        7     -            -
 Loss and total comprehensive loss for the year/period        (185,117)    (383,784)
 Loss per share
 Basic and diluted                                      8     (£0.25)      (£0.72)
 Loss attributable to:
 Owners of the parent company                                 (185,117)    (383,784)
 Non-controlling interests                                    -            -

All activities in both the current and the prior period relate to continuing
operations.

The notes below form part of these consolidated financial statements.

 

Consolidated Statement of Financial Position

As at 31 December 2022

                                    31 December  31 December  31 December  31 December
                                    2022         2022         2021         2021
                              Note  £            £            £            £
 Current assets
 Cash and cash equivalents    11    244,948                   432,440
 Trade and other receivables  12    6,866                     1,169
 Total current assets                            251,814                   433,609
 Total assets                                    251,814                   433,609
 Current liabilities
 Trade and other payables     13    83,089                    80,080
 Total current liabilities                       83,089                    80,080
 Total liabilities                               83,089                    80,080
 Total net assets                                168,725                   353,529
 Equity
 Issued share capital         15                 7,500                     7,500
 Share premium                16                 729,598                   729,598
 Capital redemption reserve   16                 2                         2
 Share-based payment reserve  18                 459                       146
 Non-controlling interest     16                 67                        67
 Retained deficit             16                 (568,901)                 (383,784)
 Total equity                                    168,725                   353,529

The consolidated financial statements were approved and authorised for issue
by the Board on 26 April 2023 and were signed on its behalf by:

David Williams

Chairman

The notes below form part of these consolidated financial statements.

 

Consolidated Statement of Changes in Equity

For the year ended 31 December 2022

                                                                                             Share-
                                                                                 Capital     based    Non-
                                                              Share    Share     redemption  payment  controlling  Retained
                                                              capital  premium   reserve     reserve  interest     deficit    Total
                                                        Note  £        £         £           £        £            £          £
 Balance at incorporation                                     2        -         -           -        -            -          2
 Loss for the period                                          -        -         -           -        -            (383,784)  (383,784)
 Transactions with owners in their capacity as owners:
 Issue of new ordinary shares                           15    7,498    742,498   2           -        67           -          750,065
 Ordinary share issue costs                                   -        (12,900)  -           -        -            -          (12,900)
 Share-based payment                                    18    -        -         -           146      -            -          146
 At 31 December 2021                                          7,500    729,598   2           146      67           (383,784)  353,529
 Loss for the year                                            -        -         -           -        -            (185,117)  (185,117)
 Transactions with

 owners in their

 capacity as owners:
 Share-based payment                                    18    -        -         -           313      -            -          313
 At 31 December 2022                                          7,500    729,598   2           459      67           (568,901)  168,725

The notes below form part of these consolidated financial statements.

 

Consolidated Statement of Cash Flows

For the year ended 31 December 2022

                                                                              9 month
                                                            Year ended        period ended
                                                            31 December 2022  31 December 2021
                                                            £                 £
 Operating activities
 Loss before taxation                                       (185,117)         (383,784)
 Adjustments for:
 Share-based payment charge                                 313               146
 Operating cash flows before changes in working capital     (184,804)         (383,638)
 Increase in trade and other receivables                    (5,697)           (1,169)
 Increase in trade and other payables                       3,009             80,147
 Net cash outflows from operating activities                (187,492)         (304,660)
 Financing activities
 Issue of ordinary shares net of issue costs                -                 750,000
 Ordinary share issue costs                                 -                 (12,900)
 Net cash inflows from financing activities                 -                 737,100
 Net (decrease)/ increase in cash and cash equivalents      (187,492)         432,440
 Cash and cash equivalents at beginning of the year/period  432,440           -
 Cash and cash equivalents at end of the year/period        244,948           432,440

The notes below form part of these consolidated financial statements.

 

Notes forming part of the Consolidated Financial Statements

For the year ended 31 December 2022

1 General information

The Company was incorporated in the prior period on 25 March 2021 as Acceler8
Ventures Limited, a private limited company under the laws of Jersey with
registered number 134586. On 17 May 2021, the Company was re-registered as an
unlisted public limited company and its name was changed to Acceler8 Ventures
Plc. On 19 July 2021 the Company shares were admitted to trading onto the Main
Market of the London Stock Exchange. The Company is the parent company of
Acceler8 Ventures Subco Limited (a private limited company under the laws of
Jersey with registered number 134587).

The address of its registered office is 28 Esplanade, St. Helier, Channel
Islands, JE2 3QA, Jersey. The Group has been incorporated for the purpose of
identifying suitable acquisition opportunities in accordance with the Group's
investment and acquisition strategy with a view to creating shareholder value.
The Group will retain a flexible investment and acquisition strategy which
will, subject to appropriate levels of due diligence, enable it to deploy
capital in target companies by way of minority or majority investments, or
full acquisitions where it is in the interests of shareholders to do so. This
will include transactions with target companies located in the UK and
internationally.

2 Accounting policies

The accounting policies set out below have, unless otherwise stated, been
applied consistently to all periods presented in theses consolidated financial
statements.

The principal policies adopted in the preparation of the consolidated
financial statements are as follows:

(a) Basis of preparation

These consolidated financial statements have been prepared in accordance with
the requirements of International Financial Reporting Standards as adopted by
the United Kingdom ("IFRS") and the requirements of the Companies (Jersey) Law
1991.

The consolidated financial statements are prepared on the historical cost
basis.

The comparative figures presented cover the nine-month period from
incorporation on 25 March 2021 to 31 December 2021.

(b) Basis of consolidation

The consolidated financial statements present the results of the Company and
its subsidiaries (the "Group") as if they formed a single entity. Intercompany
transactions and balances between Group companies are therefore eliminated in
full.

Where the Group has control over a Company, it is classified as a subsidiary.
The Group controls a Company if all three of the following elements are
present: power over the Company, exposure to variable returns from the
Company, and the ability of the Group to use its power to affect those
variable returns. Control is reassessed whenever facts and circumstances
indicate that there may be a change in any of these elements of control.

The consolidated financial statements incorporate the results of business
combinations using the acquisition method. In the consolidated statement of
financial position, the acquiree's identifiable assets, liabilities and
contingent liabilities are initially recognised at their fair values at the
acquisition date. The acquisition related costs are included in the
consolidated statement of comprehensive income on an accruals basis. The
results of acquired operations are included in the consolidated statement of
comprehensive income from the date on which control is obtained.

(c) Functional and presentational currency

The Group's functional and presentational currency for these financial
statements is the pound sterling.

(d) Going concern

The Directors, having made due and careful enquiry, are of the opinion that
the Group has adequate working capital to execute its operations over the next
12 months. The Group's unaudited cash balance as at 21 April 2023 was
£162,521, and excluding the consummation of any investment or acquisition
which will likely require specific funding, has adequate resources available
to fund the on-going forecasted operating expenses for at least twelve months
following approval of the financial statements. Having also performed
additional stress testing on the forecasts, the Directors are comfortable
there are sufficient mitigating actions on the incurring of expenditure within
the business that could be taken, to ensure the business can meet its ongoing
liabilities as they fall due. The Directors, therefore, have made an informed
judgement, at the time of approving the financial statements, that there is a
reasonable expectation that the Group has adequate resources to continue in
operational existence for the foreseeable future. As a result, the Directors
have adopted the going concern basis of accounting in preparing the annual
financial statements.

(e) Employee benefits

Short-term benefits

Short-term employee benefit obligations are measured on an undiscounted basis
and are expensed as the related service is provided. A liability is recognised
for the amount expected to be paid under short-term cash bonus or
profit‑sharing plans if the Group has a present legal or constructive
obligation to pay this amount as a result of past service provided by the
employee and the obligation can be estimated reliably.

(f) Taxation

Tax on the profit or loss for the year comprises current and deferred tax. Tax
is recognised in the income statement except to the extent that it relates to
items recognised in other comprehensive income or directly in equity, in which
case it is recognised in other comprehensive income or equity respectively.

Current tax is the expected tax payable or receivable on the taxable income or
loss for the year, using tax rates and laws enacted or substantively enacted
at the balance sheet date.

Deferred tax is provided on temporary differences between the carrying amounts
of assets and liabilities for financial reporting purposes and the amounts
used for taxation purposes. The following temporary differences are not
provided for: the initial recognition of goodwill; the initial recognition of
assets or liabilities that affect neither accounting nor taxable profit other
than in a business combination, and differences relating to investments in
subsidiaries to the extent that they will probably not reverse in the
foreseeable future. The amount of deferred tax provided is based on the
expected manner of realisation or settlement of the carrying amount of assets
and liabilities, using tax rates and laws enacted or substantively enacted at
the balance sheet date.

A deferred tax asset is recognised only to the extent that it is probable that
future taxable profits will be available against which the temporary
difference can be utilised.

(g) Cash and cash equivalents

Cash and cash equivalents comprise cash balances and short-term deposits with
an original maturity of three months or less from inception, held for meeting
short term commitments.

(h) Financial assets and liabilities

The Group's financial assets and liabilities comprise cash and cash
equivalents and accruals. Financial assets are stated at amortised cost less
provision for expected credit losses. Financial liabilities are stated at
amortised cost.

(i) Share-based payments

The Group operates an equity-settled share-based payment plan. The fair value
of the employee services received in exchange for the grant of options is
recognised as an expense over the vesting period, based on the Group's
estimate of awards that will eventually vest, with a corresponding increase in
equity as a share-based payment reserve.

This plan includes market-based vesting conditions for which the fair value at
grant date reflects and are therefore not subsequently revisited. The fair
value is determined using a binomial model.

(j) Accounting standards issued

The following amendments to standards were issued and adopted in the year,
with no material impact on the financial statements (all effective for annual
periods beginning on or after 1 January 2022):

·          Reference to the Conceptual Framework - Amendments to
IFRS 3

·          Onerous Contracts - Cost of Fulfilling a Contract -
Amendments to IAS 37

·          Annual Improvements to IFRS Standards 2018-2020

There were no other new accounting standards issued that have been adopted in
the year.

(k) Standards in issue but not yet effective

At the date of authorisation of these financial statements there were
amendments to standards which were in issue, but which were not yet effective,
and which have not been applied. The principal ones are detailed below. The
Directors do not expect the adoption of these amendments to standards to have
a material impact on the financial statements.

Deferred Tax related to Assets and Liabilities arising from a Single
Transaction (Amendments to IAS 12)

·          The amendments narrow the scope of the initial
recognition exemption to exclude transactions that give rise to equal and
offsetting temporal differences e.g. leases and decommissioning liabilities.

·          For such transactions, the associated deferred tax assets
and liabilities will need to be recognised from the beginning of the earliest
comparative period presented, with any cumulative effect recognised as an
adjustment to retained earnings or other components of equity at that date.

·          For all other transactions, the amendments apply to
transactions that occur after the beginning of the earliest period presented.

·          The amendments are effective for financial years
beginning on or after 1 January 2023 and are endorsed by the UK Endorsement
Board ("UKEB").

Disclosure of Accounting Policies (Amendments to IAS 1 and IFRS Practice
Statement 2)

·          The amendments to IAS 1 require companies to disclose
their material accounting policy information rather than their significant
accounting policies. The amendments to IFRS Practice Statement 2 provide
guidance on how to apply the concept of materiality to accounting policy
disclosures.

·          The amendments are effective for financial years
beginning on or after 1 January 2023 and are endorsed by the UKEB.

Definition of Accounting Estimates (Amendments to IAS 8)

·          The amendments clarify how companies should distinguish
changes in accounting policies from changes in accounting estimates. That
distinction is important because changes in accounting estimates are applied
prospectively only to future transactions and other future events, but changes
in accounting policies are generally also applied retrospectively to past
transactions and other past events.

·          The amendments are effective for financial years
beginning on or after 1 January 2023 and are endorsed by the UKEB.

Non-Current Liabilities with Covenants (Amendments to IAS 1)

·          The amendments to IAS 1 specify that covenants to be
complied with after the reporting date do not affect the classification of
debt as current or non-current at the reporting date.

·          The amendments require a company to disclose more
information regarding loan covenants in the notes to the financial statements
and require identification of which loans are affected by covenants.

·          The amendments are effective for financial years
beginning on or after 1 January 2024 and are not yet endorsed by the UKEB.

Classification of Liabilities as Current or Non-current (Amendments to IAS 1)

·          The amendments, as issued in 2020, aim to clarify the
requirements on determining whether a liability is current or non-current, and
apply for annual reporting periods beginning on or after 1 January 2023.

·          The International Accounting Standards Board ("IASB") has
subsequently proposed further amendments to IAS 1 and the deferral of the
effective date of the 2020 amendments to no earlier than 1 January 2024. The
amendments are not yet endorsed by the UKEB.

IFRS 17 Insurance Contracts

·          IFRS 17 replaces IFRS 4 and sets out substantial
requirements for the accounting of insurance contracts along with detailed
disclosure.

·          The Group and Company are not insurers and have not
previously entered into contracts that fall within the scope of IFRS 4 to be
treated as insurance contracts. Therefore, this standard is not deemed to be
relevant to the Group at this time and is not expected to have a significant
impact on the Group's consolidated financial statements.

·          The new standard is effective for financial years
beginning on or after 1 January 2023 has been endorsed by the UKEB.

Lease liability in a sale and leaseback transaction (Amendments to IFRS 16)

·          The amendments to IFRS 16 change the basis of calculation
of a gain or loss arising on a sale and leaseback transaction to better
reflect in terms of economic substance, the lessee's retained ownership
interest.

·          The Group and Company do not currently hold any sale and
leaseback arrangements. Therefore, these amendments are not deemed to be
relevant to the Group at this time and are not expected to have a significant
impact on the Group's consolidated financial statements.

·          The amendments are effective for financial years
beginning on or after 1 January 2023 and are not yet endorsed by the UKEB.

3 Accounting estimates and judgements

In preparing the consolidated financial statements, the Directors have to make
judgments on how to apply the Group's accounting policies and make estimates
about the future. The Directors do not consider there to be any critical
judgments that have been made in arriving at the amounts recognised in the
consolidated financial statements with the exception of the valuation of
share-based payments. Please see Note 18 for further details.

4 Employees

Staff costs, including Directors, consist of:

                                      9 month
                         Year ended   period ended
                         31 December  31 December
                         2022         2021
                         £            £
 Wages and salaries      40,000       20,000
                         40,000       20,000

 

                                                                                              9 month
                                                                                 Year ended   period ended
                                                                                 31 December  31 December
                                                                                 2022         2021
                                                                                 Number       Number
 The average number of employees, including Directors, during the year was:      2            2

5 Directors' remuneration

The Company Directors are considered the only key management personnel and
their remuneration was as follows:

                                     9 month
                        Year ended   period ended
                        31 December  31 December
                        2022         2021
                        £            £
 Directors' emoluments  40,000       20,000
                        40,000       20,000

6 Operating loss

                                                                                             9 month
                                                                                Year ended   period ended
                                                                                31 December  31 December
                                                                                2022         2021
                                                                                £            £
 This has been arrived at after charging:
 Professional services                                                          112,229      244,328
 Listing expenses                                                               -            56,549
 Fees payable to the Company's independent auditor for the audit of the parent  22,000       20,000
 and consolidated accounts

7 Taxation

                                                             9 month
                                                Year ended   period ended
                                                31 December  31 December
                                                2022         2021
                                                £            £
 Jersey corporation tax
 Corporation tax on loss for the year           -            -
 Total taxation on loss on ordinary activities  -            -

 

                                                                                9 month
                                                                   Year ended   period ended
                                                                   31 December  31 December
                                                                   2022         2021
                                                                   £            £
 Loss before tax                                                   (185,117)    (383,784)
 Tax for financial service companies at 10% (2021: 10%)            (18,512)     (38,378)
 Effect of:
 Tax losses on which a deferred tax asset has not been recognised  18,512       38,378
 Total taxation on loss on ordinary activities                     -            -

Deferred tax assets are recognised to the extent that it is probable that
taxable profits will be available against which the deductible temporary
differences and carry forward tax losses/credits can be utilised. Accordingly,
the Group has not recognised deferred tax assets in respect of deductible
temporary differences and carry forward tax losses as at 31 December 2022 and
31 December 2021 respectively, as it is not probable at year end that relevant
taxable profits will be available in future based on the current activities of
the Group as a holding group. There are no expiry dates on these tax losses as
at the year end. The unrecognised deferred tax asset is summarised below:

Tax losses and unrecognised deferred tax asset carried forward

                                                                    2022     2021
                                                                    £        £
 Cumulative temporary differences and carry forward tax losses      568,901  383,784
 Unrecognised deferred tax asset on above at 10% (based on the
 enacted tax rate at the date of signing the financial statements)  56,890   38,378

8 Earnings per share

Earnings per share is calculated by dividing the loss after tax for the year
by the weighted average number of shares in issue for the year, these figures
being as follows:

                                                                        9 month
                                                           Year ended   period ended
                                                           31 December  31 December
                                                           2022         2021
                                                           £            £
 Loss used in basic and diluted EPS, being loss after tax  (185,117)    (383,784)
 Adjustments:
 Share-based payment charge                                313          146
 Adjusted earnings used in adjusted EPS                    (184,804)    (383,638)

The Subco Incentive Scheme share options (Note 18) have not been included in
the diluted EPS on the basis that they are anti-dilutive, however they may
become dilutive in future periods.

                                                                                             9 month
                                                                                Year ended   period ended
                                                                                31 December  31 December
                                                                                2022         2021
                                                                                Number       Number
 Weighted average number of ordinary shares of 1p each used as the denominator  750,000      529,360
 in calculating basic and diluted EPS
 Earnings/(loss) per share
 Basic and diluted                                                              (£0.25)      (£0.72)
 Adjusted - basic and diluted                                                   (£0.25)      (£0.72)

9 Adjusted earnings before interest, tax, depreciation and amortisation
(Adjusted EBITDA)

                                          9 month
                             Year ended   period ended
                             31 December  31 December
                             2022         2021
                             £            £
 Loss before tax             (185,117)    (383,784)
 EBITDA loss                 (185,117)    (383,784)
 Share-based payment charge  313          146
 Adjusted EBITDA loss        (184,804)    (383,638)

10 Subsidiaries

The Company directly owns the ordinary share capital of its subsidiary
undertakings as set out below:

                                                                         Proportion of  Proportion of
                                                                         A ordinary     B ordinary
                                  Nature                Country of       shares held    shares held
 Subsidiary                       of business           incorporation    by Company     by Company
 Acceler8 Ventures Subco Limited  Intermediate holding  Jersey, Channel  100 per cent.  0 per cent.
                                  company               Islands

The address of the registered office of Acceler8 Ventures Subco Limited (the
"Subco") is 28 Esplanade, St. Helier, Channel Islands, JE2 3QA, Jersey. The
Subco was incorporated on 25 March 2021.

The A ordinary shares have full voting rights, full rights to participate in a
dividend and full rights to participate in a distribution of capital. The B
ordinary shares have been issued pursuant to the Company's Subco Incentive
Scheme.

11 Cash and cash equivalents

                            2022     2021
                            £        £
 Cash and cash equivalents  244,948  432,440
                            244,948  432,440

12 Trade and other receivables

              2022   2021
              £      £
 Prepayments  6,866  1,169
              6,866  1,169

13 Trade and other payables

                                   2022    2021
 Current trade and other payables  £       £
 Accruals                          83,089  80,080
                                   83,089  80,080

14 Financial instruments

The Group's financial assets and liabilities comprise cash and trade and other
payables. The carrying value of all financial assets and liabilities equals
fair value given their short-term nature.

                                Financial assets measured
                                at amortised cost
                                2022              2021
                                £                 £
 Current financial assets
 Cash and cash equivalents      244,948           432,440
                                244,948           432,440

                                Financial liabilities measured
                                at amortised cost
                                2022              2021
                                £                 £
 Current financial liabilities
 Accruals                       83,089            80,080
                                83,089            80,080

Credit risk

The Group's credit risk is wholly attributable to its cash balance. All cash
balances are held at a reputable bank in Jersey. The credit risk from its cash
and cash equivalents is deemed to be low due to the nature and size of the
balances held.

Liquidity risk

Liquidity risk is the risk that the Group will not be able to meet its
financial obligations as they fall due.

The Group's approach to liquidity risk is to ensure that sufficient liquidity
is available to meet foreseeable requirements and to invest funds securely and
profitably.

The following table details the contractual maturity of financial liabilities
based on the dates the liabilities are due to be settled:

Financial liabilities:

                      Less                       More
                      than 1 year  2 to 5 Years  than 5 years  Total
                      £            £             £             £
 Accruals             83,089       -             -             83,089
 At 31 December 2022  83,089       -             -             83,089

15 Share capital

                              Allotted, called up and fully paid
                              2022       2021       2022       2021
                              Number     Number     £          £
 Ordinary shares of 1p each:  750,000    750,000    7,500      7,500
 At 31 December 2022          750,000    750,000    7,500      7,500

On incorporation on 25 March 2021, the Company had an authorised share capital
of £10,000.00 divided into 10,000 ordinary shares of par value of £1 each,
of which one ordinary share was issued to each of the Founders. The two
ordinary shares were each issued for consideration of £1.00 per share.

On 18 May 2021, the Company sub-divided its share capital. Pursuant to the
sub-division, the two ordinary shares of £1.00 each in the issued share
capital of the Company were split into 200 ordinary shares. Following the
sub-division, 198 ordinary shares were re-designated as deferred shares of par
value £0.01 each. Following the sub-division and re-designation: the issued
share capital of the Company was comprised of 2 ordinary shares and 198
deferred shares; and the Company had an authorised share capital of £10,002
divided into 1,000,000 ordinary shares of par value £0.01 each and 200
deferred shares of a par value £0.01 each. The deferred shares were redeemed
and subsequently cancelled, with a capital redemption reserve created of
equivalent value as per Note 16.

On 21 May 2021, the Company issued and allotted 399,998 Ordinary Shares at a
price of £1.00 per ordinary share to the Founders, for aggregate
consideration of £399,998 in cash. Immediately following that issue and
allotment, the issued share capital of the Company was comprised of 400,000
ordinary shares and 198 deferred shares.

On 21 May 2021, in accordance with article 5B of the Articles, the Company
redeemed for nil consideration the deferred shares. Any amounts standing to
the credit of any nominal or share premium account relating to deferred shares
that were redeemed were credited to a capital reserve of the Company and are
available for use in accordance with the Companies Law.

On 24 May 2021, the Company issued and allotted 25,000 ordinary shares at a
price of £1.00 per ordinary share, for aggregate consideration of £25,000 in
cash. Immediately following that issue and allotment, the issued share capital
of the Company was comprised of 425,000 ordinary shares.

Pursuant to the IPO placing, 325,000 ordinary shares were issued and allotted
at a price of £1.00 per ordinary share to certain new investors.

Immediately following this issue and allotment, the Company's issued share
capital increased to 750,000 ordinary shares. All shares are equally eligible
to receive dividends and the repayment of capital and represent one vote at
the shareholders' meeting of the Company.

16 Reserves

Share premium and retained earnings represent balances conventionally
attributed to those descriptions. The transaction costs relating to the issue
of shares was deducted from share premium.

Capital redemption reserve includes amounts in relation to deferred shared
capital.

The Group having no regulatory capital or similar requirements, its primary
capital management focus is on maximising earnings per share and therefore
shareholder return.

The non-controlling interests reserves arises out of amounts due to holders of
the B shares in Acceler8 Ventures Subco Limited.

The Directors have proposed that there will be no final dividend in respect of
2022 (2021: £Nil).

17 Share Incentive Plan

On 14 July 2021, the Group created a Subco Incentive Scheme within its wholly
owned subsidiary Acceler8 Ventures Subco Limited ("Subco"). Under the terms of
the Subco Incentive Scheme, scheme participants are only rewarded if a
predetermined level of shareholder value is created over a three to five year
period or upon a change of control of the Company or Subco (whichever occurs
first), calculated on a formula basis by reference to the growth in market
capitalisation of the Company, following adjustments for the issue of any new
Ordinary shares and taking into account dividends and capital returns
("Shareholder Value"), realised by the exercise by the beneficiaries of a put
option in respect of their shares in Subco and satisfied either in cash or by
the issue of new ordinary shares at the election of the Company.

Under these arrangements in place, participants are entitled to up to 15 per
cent. of the Shareholder Value created, subject to such Shareholder Value
having increased by at least 12.5 per cent. per annum compounded over a period
of between three and five years from admission or following a change of
control of the Company or Subco.

18 Share-based payments

The Subco Incentive Scheme detailed in Note 17 is an equity-settled share
option plan which allows employees and advisors of the Group to sell their B
shares to the Company in exchange for a cash payment or for shares in the
Company (at the Company's election) if certain conditions are met.

These conditions include good and bad leaver provisions and that growth in
Shareholder Value of 12.5 percent compound per annum is delivered over a three
to five year period for the scheme to vest. This second condition is therefore
a market condition which has been taken into account in the measurement at
grant date of the fair value of the options.

The weighted average exercise price of the outstanding B share options is
£Nil which have a weighted average contractual life of 3 years 9 months.
29,000 B share options were issued in the nine-month period to 31 December
2021, all of which were outstanding at the current year end. No B share
options were exercised in the current or prior period. No B share options have
expired during the current or prior period.

The Group recognised £313 (2021: £146) of expenditure in the statement of
total comprehensive income in relation to equity-settled share-based payments
in the year.

The fair value of options granted during the period is determined by applying
a binominal model. The expense is apportioned over the vesting period of the
option and is based on the number which are expected to vest and the fair
value of these options at the date of grant.

The inputs into the binomial model in respect of options granted in the prior
period are as follows:

 Opening share price                       £1
 Expected volatility of share price        16.67%
 Expected life of options                  5 years
 Risk-free rate                            0.71%
 Target increase in share price per annum  12.5%
 Fair value of options                     5.397p

Expected volatility was estimated by reference to the average 5-year
volatility of the FTSE SmallCap Index.

The target increase in Shareholder Value is laid out in the Articles of
Association of the Subco and represents the compounded target annual increase
in market capitalisation (adjusted for capital raises and dividends) that
needs to be met between the third and fifth anniversary of the Group's
admission onto the Main Market of the London Stock Exchange in order for the
scheme to vest.

The Group did not enter into any share-based payment transactions with parties
other than employees and advisors during the current or prior period.

19 Related party transactions

Transactions with key management personnel

Key management personnel comprise the Directors and executive officers. The
remuneration of the individual Directors is disclosed in the Report of the
Directors.

Other transactions - Group

On 14 May 2021, the Company entered into an arm's length strategic advisory
agreement with Tessera pursuant to which Tessera has agreed to provide
strategic and general corporate advice, and acquisition and capital raising
transaction support services to the Company. Tessera was entitled to an
initial transaction fee of £100,000 (plus VAT) payable on admission for
transaction management services provided to the Company in connection with
admission and capital raising activities.

From admission, Tessera will provide strategic advisory services and will be
paid a success fee on completion on the first acquisition, at an amount to be
agreed between Tessera and the Company. Following completion of the first
acquisition, Tessera will provide services as requested by the Company and
will charge a fixed daily rate or monthly retainer fee depending on the volume
of such services. As at 31 December 2022, £1,011 (2021: £Nil) was owed to
Tessera by the Company.

20 Post balance sheet events

There are no events subsequent to the reporting date which would have a
material impact on the financial statements.

21 Contingent liabilities

There are no contingent liabilities at the reporting date which would have a
material impact on the financial statements.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  FR PPUUCCUPWUAM

Recent news on Acceler8 Ventures

See all news